In fact, this could lead to an increased risk of side effects, such as nausea, vomiting, low blood sugar, and other complications
This is important, especially when your body is healing or undergoing treatments like chemotherapy
[9] [10] Importantly, the VAT-reducing effect of tesamorelin diminishes after treatment is stopped, and VAT can reaccumulate following discontinuation
The same injection used for tirzepatide can also cause allergic reactions, which should be monitored closely
[25] [26] Based on its overexpression in a majority of human tumor cell lines and prevalence in chemotherapeutic-resistant tumors, GSTP1-1 is thought to play a role in the development of cancer and its potential resistance to drug treatment